Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no. . 45K. Even if these collaborations have beenterminated, the market deserves to know about it. - 12:30 p. Dr. ASX - By Stock. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. Share I sometimes wonder if they actually work at Starpharma. . 75802. SPL. and I dont like what I am seeing. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . Created with Sketch. Created with Sketch. Surely the political restraints. Attached link highlights some of the complexities involved more broadly. Created with Sketch. 16,364,160. Latest Posts. Join the HotCopper ASX share market forum today for free. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. ASX - By Stock. Join the HotCopper ASX share market forum today for free. Discussion. m. 9¢. 0¢. Created with Sketch. . ASX - General. We love cruising, but this multi billion dollar industry has effectively been shut down. Hey, "smart", I concur with your message. Last updated 15. We had a Dec 2021 DCB of around the FIB 23. Last updated 15. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. 49M. 0000. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. The last time was December 2018. ASX - Day TradingSo the share price of SPL rose up to a high of $2. Market . Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. ASX - By Stock. I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. ASX - By Stock. Safety, tolerability and side effects appear to be superior to all the base drugs, and that should be enough to sell the licenses. ” This, sadly, is not true. 0¢. That won’t be a shock to. 38. Shouldn’t company have announced departure of key person when. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Forums. As of 2015, HotCopper was in the top 170 websites in Australia and was. 0000. NEW YORK TRANSN DEV CORP SPL FAC REV 4. 00. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. Click for more information. . This is a charting thread for those interested in the movements of the SPL SP. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. Surely, surely these great technical achievements will translate into commercial gains for the company and us long suffering SPL Shareholders. NSX - By Stock. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. 0¢ Sentiment: Buy. Created with Sketch. Latest Posts. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. Advertise on HotCopper. 37. granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. 8985. Imo, financial things such as deals, sales and. Target our investor community with our. Latest Posts. J K Fairley $1,272,084N J Baade. . Jackie in the discussion talked about dealing with the tourist industry. Hey, "smart", I concur with your message. 0¢. Volume. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. ”For your information 55% of the company is held by institutions” ~ AB I. . Market . ASX - By Stock. Don’t look to him for the truth lol. . 15667. SPL have hit road blocks with many of their products. Created with Sketch. HotCopper is Australia's largest free and independent stock market trading forum for. 0. My theory is we had a large accumulator that was content buying. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. ASX - By Stock. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. ASX - Day TradingCreated with Sketch. * The Viraleze trial will be completed. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. A correctly formatted example follows: Title of my presentation for the conference. SPL Price at posting: 16. 70. “It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other. SPL Price at posting: 44. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - Day Trading. It is because SPL has abrogated the marketing role to its distributors. The total and absolute shame of this is that not once in their quarter of a century of existence have these "discussions" amounted to a deal. So far no one wants to add anything except to get. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 3¢. 5¢ Sentiment: Hold Disclosure: HeldThat's so funny col69 Antibotter post had you scrambling to find the link where he got that information then you copy paste the link and infer you knew already, if you did know you would for sure have posted this morning, some posters knew you were not one of them imo, still should have been an announcement let's hope results once collated. Additionally, three of the companies mentioned that have approved and marketed IO. ASX - By Stock. IPOs. 0¢. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 4. Created with Sketch. and as I said I met @Domesticgod there, which was a pleasure. ASX - By Stock. ASX - By Stock. . ASX - Day Trading. 5¢. Latest Posts. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. I think SPL are very worried on what a potential class action could implicate. 5230. You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. . Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. . Latest Posts. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. ASX - Day Trading. also not sure why anyone should get excited about a daily decrease in the short position of 0. ASX - General. Created with Sketch. For a small cap like spl where the revenue stream created would be very large in the context of our current. Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. See All Discussions. SPL Price at posting: 71. As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. However, I think that maybe SPL is occasionally worth a swing trade gamble. Charts. Market Cap $77. 56. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Forums. ASX - Day Trading. Join the HotCopper ASX share market forum today for free. ASX - By Stock. Hey, "smart", I concur with your message. Some paralllels with SPL, although every product and data is different, but a least MSB are pretty clear with CRL - not pretty fro shareholders and going to take a lot of funding and dillution to achieve trial that could have been completesd in that same timeframe and IMO a lower risk. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Market Cap $58. SPL's current SP is about 15 cents, after many years (some say 20 years) of unprofitability, during which time substantial salaries and performance bonuses appear to have been paid. Enter the title of your abstract. Advertise on HotCopper. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. Working in a. 03% or subsequently a decrease in shorts of. Latest Posts. Hey, "smart", I concur with your message. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. ASX - By Stock. SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. municipal. 0¢. LEADING THE BATTERY METALS REVOLUTION. Join the HotCopper ASX share market forum today for free. . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 1dB. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. Charts. Yes I am sure @sarge17 some will come on here today that have been predicting a $2 share price for more than 6 months because it has finally hit that target today saying “I toldNotification of cessation of securities - SPL. $0. 63M. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. ASX - Day Trading. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 59pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. The thread is titled so that it can be found and general enough so as to. 70. 50 peak) that they hadn’t missed the boat and that SPL was soon going to $3. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. The bait SPL have put out about models and publishing in 3 weeks should be stopped by ASX / ASIC and teh timing is odd IMO. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. FORTESCUE METALS GROUP LTD. ASX - By Stock. 0¢. All ETFs by Morningstar Ratings Morningstar Medalist Rating Gold. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. 4¢. Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. Created with Sketch. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. Market Cap $. 48. Join the HotCopper ASX share market. - 12:30 p. ASX - By Stock. . 36. . . 0¢. bc. Last updated 15. 5. 00% 14. 8¢. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. . 43M. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . So on the one hand you state SPL isn't a nasal spray company. Target our investor community with our. While the chart is not good there is a glimmer hope maybe emerging. Latest Posts. Last updated 15. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. m. . This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. 19/09/23. They are the future as also mentioned regularly by Eric Topol. Yes I think SPL does have a future but TIME is of the essence. Their IP doesn't last forever - you need to hustle in pharma. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. $1. 8985. ASX - By Stock. HotCopper has news,. Hey, "smart", I concur with your message. Norman Swan interviewed on ABC RN Breakfast talks about Covid Nasal vaccines and blockers. Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. Created with Sketch. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. This sort of action happens fairly often with SPL then followed by a pull back. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. Advertise on HotCopper. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Forums. Twenty years later it’s 84. Follow your favourite stocks, view charts, track. . 8. Forums. Latest Posts. 2. Advertise on HotCopper. Target our investor community with our suite of Hotcopper Advertising opportunities. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. 3. ASX - By Stock. 5¢. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. The Vancouver Island Wave program is the Island’s highest level of youth soccer participating in the BC Soccer Premier League. OR no reponse at all. In March 2020 the SPL share price dropped to a low of 0. 6. The matter has been adjourned to. 28pm 13/11/2023 ? TMG (ASX) Chart. 7¢. . I remember seeing a post on SPL had 41000 views. The recent announcement about Viraleze nasal. Interesting write-up. ASX - General. Last updated 10. The upper and lower pennant lines will intersect in three months. 3¢. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Thanks for all your hard work and many successes during the year. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . ASX - General. So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. rights. 75. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. 37 Sentiment: Buy Disclosure: Held. . 37. BCSPL – VI Wave. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. ASX - By Stock. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. Join the HotCopper ASX share market forum today for free. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 72. Hey, "smart", I concur with your message. It totally unrealistic that Merck will enter the clinic in 4-5 months. Starpharma AGM Summary (Part 1) Oh. . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Created with Sketch. Created with Sketch. See All Discussions. 5¢. Interesting write-up. Join the HotCopper ASX share market forum today for free. 30. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. In SPL's case there is clearly another. $0. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. Just begin to imagine that all staff on board use Viraleze well before. We know that they haven't been marketed well but i think BigPharma have had an input. . and even when Big pharma are challenged legally and lose in court as in Johnson and Johnson bladder slings - its 20 years after the tort, 8 yrs fighting in court to then be waiting waiting waiting for compensation not for pain and suffering in VICTORIA just inconvenience costs such as buying pads and pain killers. Change in substantial holding. I should declare that I am. Share Interesting and positive early pre-clinical results. , page-2. 5. 3¢. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. . 971M ! Add to my watchlist. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. And he still is Chairman or Director of SIX other companies. 5¢. 5. Latest Posts. Prior to the trial results being released SPL need to get on the front foot. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Last updated 15. The SP must break out of the.